Haematology in BRICS Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017

Report Summary

GlobalData’s new report, “Haematology in BRICS Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017” provides key market data on the Haematology market in the BRICS countries. The report provides value ($m) data for each segment and sub-segment within six market categories – Haematology Reagents, Haemostasis, Immunohaematology, Haematology Rapid Tests, Haematology Analyzers and Haematology Cell Counters. The report also provides company shares and distribution shares data for the overall Haematology market in each of the aforementioned countries. The report is also supplemented with global corporate-level profiles of the key market participants with information on key developments, wherever available.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

The emerging economies, comprising China, India, Brazil, Russia and South Africa, with a significantly large pool of under-served patients, represent the next big opportunity for the leading medical equipment and devices manufacturers. China remains the world’s most populous country and is consequently home to a large patient base. The country is home to more than 120 million people who are aged 65 or older—a population in continuous need of medical care. India, the second most populous country globally, is home to 1.2 billion people, approximately 5% of which are aged 65 or older. It’s estimated that shortly after 2020, India’s population will surpass China, making it the most populous country in the world. As the population continues to grow and people continue to age, the underlying demand for healthcare is also expected to increase.

Scope

• Market size data for Haematology market categories – Haematology Reagents, Haemostasis, Immunohaematology, Haematology Rapid Tests, Haematology Analyzers and Haematology Cell Counters.
• Annualized market revenues ($m) data for each of the segments and sub-segments within the six market categories. Data from 2003 to 2010, forecast forward for seven years to 2017.
• 2010 company shares and distribution shares data for the overall Haematology market in each of the aforementioned countries.
• Global corporate-level profiles of key companies operating within the Haematology market in BRICS.
• Key players covered include Sysmex Corporation, Siemens Healthcare, Mindray Medical International Limited, Beckman Coulter, Inc., F. Hoffmann-La Roche Ltd., Bio-Rad Laboratories, Inc., HORIBA, Ltd., Abbott Laboratories, Transasia Bio-Medicals Ltd., Grifols, S.A., Shanghai Kehua Bio-engineering Co., Ltd., DIAGNOSTICA STAGO, Inc. and Nihon Kohden Corporation.

Reasons to buy

• Develop business strategies by identifying the key market categories and segments poised for strong growth.
• Develop market-entry and market expansion strategies.
• Design competition strategies by identifying who-stands-where in the Haematology competitive landscape in BRICS.
• Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
• What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

Table of Contents

1 Table of Contents 2
1.1 List of Tables 8
1.2 List of Figures 11

2 Introduction 14
2.1 What is This Report About? 14

3 Haematology in BRICS 15
3.1 Haematology, BRICS, Overall Revenue ($m), USD Actual 2003-2017 15
3.2 Haematology, BRICS, Company Share (2009-2010) 21

4 Haematology In Brazil 23
4.1 Haematology, Brazil, Overall Revenue ($m), USD Actual, 2003-2017 23
4.2 Haematology Reagents In Brazil 29
4.2.1 Haematology Reagents, Brazil, Overall Revenue (2003-2017) 29
4.3 Immunohaematology In Brazil 33
4.3.1 Immunohaematology, Brazil, Overall Revenue (2003-2017) 33
4.4 Haematology Cell Counters In Brazil 37
4.4.1 Haematology Cell Counters, Brazil, Overall Revenue (2003-2017) 37
4.5 Haemostasis In Brazil 41
4.5.1 Haemostasis, Brazil, Overall Revenue (2003-2017) 41
4.6 Haematology Rapid Tests In Brazil 45
4.6.1 Haematology Rapid Tests, Brazil, Overall Revenue (2003-2017) 45
4.7 Haematology Analyzers In Brazil 49
4.7.1 Haematology Analyzers, Brazil, Overall Revenue (2003-2017) 49
4.8 Haematology, Brazil, Distribution Share (2009-2010) 51
4.9 Haematology, Brazil, Company Share (2009-2010) 52

5 Haematology In Russian Federation 54
5.1 Haematology, Russian Federation, Overall Revenue ($m), USD Actual, 2003-2017 54
5.2 Haemostasis In Russian Federation 60
5.2.1 Haemostasis, Russian Federation, Overall Revenue (2003-2017) 60
5.3 Immunohaematology In Russian Federation 64
5.3.1 Immunohaematology, Russian Federation, Overall Revenue (2003-2017) 64
5.4 Haematology Reagents In Russian Federation 68
5.4.1 Haematology Reagents, Russian Federation, Overall Revenue (2003-2017) 68
5.5 Haematology Analyzers In Russian Federation 72
5.5.1 Haematology Analyzers, Russian Federation, Overall Revenue (2003-2017) 72
5.6 Haematology Rapid Tests In Russian Federation 74
5.6.1 Haematology Rapid Tests, Russian Federation, Overall Revenue (2003-2017) 74
5.7 Haematology Cell Counters In Russian Federation 78
5.7.1 Haematology Cell Counters, Russian Federation, Overall Revenue (2003-2017) 78
5.8 Haematology, Russian Federation, Distribution Share (2009-2010) 82
5.9 Haematology, Russian Federation, Company Share (2009-2010) 83

6 Haematology In India 85
6.1 Haematology, India, Overall Revenue ($m), USD Actual, 2003-2017 85
6.2 Haematology Reagents In India 91
6.2.1 Haematology Reagents, India, Overall Revenue (2003-2017) 91
6.3 Haematology Analyzers In India 95
6.3.1 Haematology Analyzers, India, Overall Revenue (2003-2017) 95
6.4 Immunohaematology In India 97
6.4.1 Immunohaematology, India, Overall Revenue (2003-2017) 97
6.5 Haemostasis In India 101
6.5.1 Haemostasis, India, Overall Revenue (2003-2017) 101
6.6 Haematology Rapid Tests In India 105
6.6.1 Haematology Rapid Tests, India, Overall Revenue (2003-2017) 105
6.7 Haematology Cell Counters In India 109
6.7.1 Haematology Cell Counters, India, Overall Revenue (2003-2017) 109
6.8 Haematology, India, Distribution Share (2009-2010) 113
6.9 Haematology, India, Company Share (2009-2010) 114

7 Haematology In China 116
7.1 Haematology, China, Overall Revenue ($m), USD Actual, 2003-2017 116
7.2 Haemostasis In China 122
7.2.1 Haemostasis, China, Overall Revenue (2003-2017) 122
7.3 Haematology Reagents In China 126
7.3.1 Haematology Reagents, China, Overall Revenue (2003-2017) 126
7.4 Haematology Rapid Tests In China 130
7.4.1 Haematology Rapid Tests, China, Overall Revenue (2003-2017) 130
7.5 Immunohaematology In China 134
7.5.1 Immunohaematology, China, Overall Revenue (2003-2017) 134
7.6 Haematology Analyzers In China 138
7.6.1 Haematology Analyzers, China, Overall Revenue (2003-2017) 138
7.7 Haematology Cell Counters In China 140
7.7.1 Haematology Cell Counters, China, Overall Revenue (2003-2017) 140
7.8 Haematology, China, Distribution Share (2009-2010) 144
7.9 Haematology, China, Company Share (2009-2010) 145

8 Haematology In South Africa 147
8.1 Haematology, South Africa, Overall Revenue ($m), USD Actual, 2003-2017 147
8.2 Haemostasis In South Africa 153
8.2.1 Haemostasis, South Africa, Overall Revenue (2003-2017) 153
8.3 Haematology Reagents In South Africa 157
8.3.1 Haematology Reagents, South Africa, Overall Revenue (2003-2017) 157
8.4 Immunohaematology In South Africa 161
8.4.1 Immunohaematology, South Africa, Overall Revenue (2003-2017) 161
8.5 Haematology Rapid Tests In South Africa 165
8.5.1 Haematology Rapid Tests, South Africa, Overall Revenue (2003-2017) 165
8.6 Haematology Analyzers In South Africa 169
8.6.1 Haematology Analyzers, South Africa, Overall Revenue (2003-2017) 169
8.7 Haematology Cell Counters In South Africa 171
8.7.1 Haematology Cell Counters, South Africa, Overall Revenue (2003-2017) 171
8.8 Haematology, South Africa, Distribution Share (2009-2010) 175
8.9 Haematology, South Africa, Company Share (2009-2010) 176

9 Overview of Key Companies in BRICS Haematology Market 178
9.1 Sysmex Corporation 178
9.1.1 Company Overview 178
9.1.2 Share in the BRICS Haematology Market 179
9.2 Siemens Healthcare 180
9.2.1 Company Overview 180
9.2.2 Share in the BRICS Haematology Market 181
9.3 Mindray Medical International Limited 182
9.3.1 Company Overview 182
9.3.2 Share in the BRICS Haematology Market 183
9.4 Beckman Coulter, Inc. 184
9.4.1 Company Overview 184
9.4.2 Share in the BRICS Haematology Market 185
9.5 F. Hoffmann-La Roche Ltd. 186
9.5.1 Company Overview 186
9.5.2 Share in the BRICS Haematology Market 187
9.6 Bio-Rad Laboratories, Inc. 188
9.6.1 Company Overview 188
9.6.2 Share in the BRICS Haematology Market 189
9.7 HORIBA, Ltd. 190
9.7.1 Company Overview 190
9.7.2 Share in the BRICS Haematology Market 191
9.8 Abbott Laboratories 192
9.8.1 Company Overview 192
9.8.2 Share in the BRICS Haematology Market 193
9.9 Transasia Bio-Medicals Ltd. 194
9.9.1 Company Overview 194
9.9.2 Share in the BRICS Haematology Market 194
9.10 Grifols, S.A. 195
9.10.1 Company Overview 195
9.10.2 Share in the BRICS Haematology Market 196
9.11 Shanghai Kehua Bio-engineering Co., Ltd. 197
9.11.1 Company Overview 197
9.11.2 Share in the BRICS Haematology Market 197
9.12 DIAGNOSTICA STAGO, Inc. 198
9.12.1 Company Overview 198
9.12.2 Share in the BRICS Haematology Market 199
9.13 Nihon Kohden Corporation 200
9.13.1 Company Overview 200
9.13.2 Share in the BRICS Haematology Market 200
9.14 Span Diagnostics Ltd. 201
9.14.1 Company Overview 201
9.15 bioMerieux S.A. 201
9.15.1 Company Overview 201
9.16 J.Mitra & Co. Pvt Ltd 201
9.16.1 Company Overview 201
9.17 Trivitron Healthcare Pvt Ltd. 202
9.17.1 Company Overview 202
9.18 Immucor, Inc. 202
9.18.1 Company Overview 202

10 Appendix 203
10.1 Definitions of Markets Covered in the Report 204
10.1.1 Haematology 204
10.2 Research Methodology 207
10.3 Secondary Research 207
10.4 Primary Research 208
10.5 Models 208
10.6 Forecasts 209
10.7 Expert Panels 209
10.8 GlobalData Consulting 209
10.9 Currency Conversion 210
10.10 Contact Us 210
10.11 Disclaimer 210

List of Tables

Table 1: Haematology, BRICS, Overall Revenue ($m), USD Actual 2003-2017 16
Table 2: Haematology, BRICS, Overall Revenue ($m), USD Actual Historic, 2003-2010 18
Table 3: Haematology, BRICS, Overall Revenue ($m), USD Actual Forecast, 2010-2017 20
Table 4: Haematology, BRICS, Company Share by Revenue ($m), USD Actual, 2009-2010 22
Table 5: Haematology, Brazil, Overall Revenue ($m), USD Actual, 2003-2017 24
Table 6: Haematology, Brazil, Overall Revenue ($m), USD Actual, Historic, 2003-2010 26
Table 7: Haematology, Brazil, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 28
Table 8: Haematology Reagents, Brazil, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 30
Table 9: Table 10: Haematology Reagents, Brazil, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 32
Table 11: Immunohaematology, Brazil, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 34
Table 12: Table 13: Immunohaematology, Brazil, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 36
Table 14: Haematology Cell Counters, Brazil, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 38
Table 15: Table 16: Haematology Cell Counters, Brazil, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 40
Table 17: Haemostasis, Brazil, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 42
Table 18: Table 19: Haemostasis, Brazil, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 44
Table 20: Haematology Rapid Tests, Brazil, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 46
Table 21: Table 22: Haematology Rapid Tests, Brazil, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 48
Table 23: Haematology Analyzers, Brazil, Revenue ($m), USD Actual, Historic, 2003-2010 49
Table 24: Table 25: Haematology Analyzers, Brazil, Revenue ($m), USD Actual, Forecast, 2010-2017 50
Table 26: Haematology, Brazil, Distribution Share by Revenue ($m), USD Actual, 2009-2010 51
Table 27: Haematology, Brazil, Company Share by Revenue ($m), USD Actual, 2009-2010 53
Table 28: Haematology, Russian Federation, Overall Revenue ($m), USD Actual, 2003-2017 55
Table 29: Haematology, Russian Federation, Overall Revenue ($m), USD Actual, Historic, 2003-2010 57
Table 30: Haematology, Russian Federation, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 59
Table 31: Haemostasis, Russian Federation, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 61
Table 32: Table 33: Haemostasis, Russian Federation, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 63
Table 34: Immunohaematology, Russian Federation, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 65
Table 35: Table 36: Immunohaematology, Russian Federation, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 67
Table 37: Haematology Reagents, Russian Federation, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 69
Table 38: Haematology Reagents, Russian Federation, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 71
Table 39: Haematology Analyzers, Russian Federation, Revenue ($m), USD Actual, Historic, 2003-2010 72
Table 40: Haematology Analyzers, Russian Federation, Revenue ($m), USD Actual, Forecast, 2010-2017 73
Table 41: Haematology Rapid Tests, Russian Federation, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 75
Table 42: Haematology Rapid Tests, Russian Federation, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 77
Table 43: Haematology Cell Counters, Russian Federation, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 79
Table 44: Haematology Cell Counters, Russian Federation, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 81
Table 45: Haematology, Russian Federation, Distribution Share by Revenue ($m), USD Actual, 2009-2010 82
Table 46: Haematology, Russian Federation, Company Share by Revenue ($m), USD Actual, 2009-2010 84
Table 47: Haematology, India, Overall Revenue ($m), USD Actual, 2003-2017 86
Table 48: Haematology, India, Overall Revenue ($m), USD Actual, Historic, 2003-2010 88
Table 49: Haematology, India, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 90
Table 50: Haematology Reagents, India, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 92
Table 51: Table 52: Haematology Reagents, India, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 94
Table 53: Haematology Analyzers, India, Revenue ($m), USD Actual, Historic, 2003-2010 95
Table 54: Table 55: Haematology Analyzers, India, Revenue ($m), USD Actual, Forecast, 2010-2017 96
Table 56: Immunohaematology, India, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 98
Table 57: Table 58: Immunohaematology, India, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 100
Table 59: Haemostasis, India, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 102
Table 60: Table 61: Haemostasis, India, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 104
Table 62: Haematology Rapid Tests, India, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 106
Table 63: Table 64: Haematology Rapid Tests, India, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 108
Table 65: Haematology Cell Counters, India, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 110
Table 66: Table 67: Haematology Cell Counters, India, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 112
Table 68: Haematology, India, Distribution Share by Revenue ($m), USD Actual, 2009-2010 113
Table 69: Haematology, India, Company Share by Revenue ($m), USD Actual, 2009-2010 115
Table 70: Haematology, China, Overall Revenue ($m), USD Actual, 2003-2017 117
Table 71: Haematology, China, Overall Revenue ($m), USD Actual, Historic, 2003-2010 119
Table 72: Haematology, China, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 121
Table 73: Haemostasis, China, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 123
Table 74: Table 75: Haemostasis, China, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 125
Table 76: Haematology Reagents, China, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 127
Table 77: Table 78: Haematology Reagents, China, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 129
Table 79: Haematology Rapid Tests, China, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 131
Table 80: Table 81: Haematology Rapid Tests, China, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 133
Table 82: Immunohaematology, China, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 135
Table 83: Table 84: Immunohaematology, China, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 137
Table 85: Haematology Analyzers, China, Revenue ($m), USD Actual, Historic, 2003-2010 138
Table 86: Table 87: Haematology Analyzers, China, Revenue ($m), USD Actual, Forecast, 2010-2017 139
Table 88: Haematology Cell Counters, China, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 141
Table 89: Table 90: Haematology Cell Counters, China, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 143
Table 91: Haematology, China, Distribution Share by Revenue ($m), USD Actual, 2009-2010 144
Table 92: Haematology, China, Company Share by Revenue ($m), USD Actual, 2009-2010 146
Table 93: Haematology, South Africa, Overall Revenue ($m), USD Actual, 2003-2017 148
Table 94: Haematology, South Africa, Overall Revenue ($m), USD Actual, Historic, 2003-2010 150
Table 95: Haematology, South Africa, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 152
Table 96: Haemostasis, South Africa, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 154
Table 97: Table 98: Haemostasis, South Africa, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 156
Table 99: Haematology Reagents, South Africa, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 158
Table 100: Table 101: Haematology Reagents, South Africa, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 160
Table 102: Immunohaematology, South Africa, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 162
Table 103: Immunohaematology, South Africa, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 164
Table 104: Haematology Rapid Tests, South Africa, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 166
Table 105: Table 106: Haematology Rapid Tests, South Africa, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 168
Table 107: Haematology Analyzers, South Africa, Revenue ($m), USD Actual, Historic, 2003-2010 169
Table 108: Table 109: Haematology Analyzers, South Africa, Revenue ($m), USD Actual, Forecast, 2010-2017 170
Table 110: Haematology Cell Counters, South Africa, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 172
Table 111: Haematology Cell Counters, South Africa, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 174
Table 112: Haematology, South Africa, Distribution Share by Revenue ($m), USD Actual, 2009-2010 175
Table 113: Haematology, South Africa, Company Share by Revenue ($m), USD Actual, 2009-2010 177
Table 114: Sysmex Corporation, Revenue ($m), USD Actual, BRICS Haematology Market, 2010 179
Table 115: Siemens Healthcare, Revenue ($m), USD Actual, BRICS Haematology Market, 2010 181
Table 116: Mindray Medical International Limited, Revenue ($m), USD Actual, BRICS Haematology Market, 2010 183
Table 117: Beckman Coulter, Inc., Revenue ($m), USD Actual, BRICS Haematology Market, 2010 185
Table 118: F. Hoffmann-La Roche Ltd., Revenue ($m), USD Actual, BRICS Haematology Market, 2010 187
Table 119: Bio-Rad Laboratories, Inc., Revenue ($m), USD Actual, BRICS Haematology Market, 2010 189
Table 120: HORIBA, Ltd., Revenue ($m), USD Actual, BRICS Haematology Market, 2010 191
Table 121: Abbott Laboratories, Revenue ($m), USD Actual, BRICS Haematology Market, 2010 193
Table 122: Transasia Bio-Medicals Ltd., Revenue ($m), USD Actual, BRICS Haematology Market, 2010 194
Table 123: Grifols, S.A., Revenue ($m), USD Actual, BRICS Haematology Market, 2010 196
Table 124: Shanghai Kehua Bio-engineering Co., Ltd., Revenue ($m), USD Actual, BRICS Haematology Market, 2010 197
Table 125: DIAGNOSTICA STAGO, Inc., Revenue ($m), USD Actual, BRICS Haematology Market, 2010 199
Table 126: Nihon Kohden Corporation, Revenue ($m), USD Actual, BRICS Haematology Market, 2010 200
Table 127: USD to Local Currency, BRICS, Average Exchange Rate, 2003-2010 210

List of Figures

Figure 1: Haematology, BRICS, Overall Revenue ($m), USD Actual 2003-2017 15
Figure 2: Haematology, BRICS, Overall Revenue ($m), USD Actual Historic, 2003-2010 17
Figure 3: Haematology, BRICS, Overall Revenue ($m), USD Actual Forecast, 2010-2017 19
Figure 4: Haematology, BRICS, Company Share (%), 2010 21
Figure 5: Haematology, Brazil, Overall Revenue ($m), USD Actual, 2003-2017 23
Figure 6: Haematology, Brazil, Overall Revenue ($m), USD Actual, Historic, 2003-2010 25
Figure 7: Haematology, Brazil, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 27
Figure 8: Haematology Reagents, Brazil, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 29
Figure 9: Haematology Reagents, Brazil, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 31
Figure 10: Immunohaematology, Brazil, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 33
Figure 11: Immunohaematology, Brazil, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 35
Figure 12: Haematology Cell Counters, Brazil, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 37
Figure 13: Haematology Cell Counters, Brazil, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 39
Figure 14: Haemostasis, Brazil, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 41
Figure 15: Haemostasis, Brazil, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 43
Figure 16: Haematology Rapid Tests, Brazil, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 45
Figure 17: Haematology Rapid Tests, Brazil, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 47
Figure 18: Haematology Analyzers, Brazil, Revenue ($m), USD Actual, Historic, 2003-2010 49
Figure 19: Haematology Analyzers, Brazil, Revenue ($m), USD Actual, Forecast, 2010-2017 50
Figure 20: Haematology, Brazil, Company Share (%), 2010 52
Figure 21: Haematology, Russian Federation, Overall Revenue ($m), USD Actual, 2003-2017 54
Figure 22: Haematology, Russian Federation, Overall Revenue ($m), USD Actual, Historic, 2003-2010 56
Figure 23: Haematology, Russian Federation, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 58
Figure 24: Haemostasis, Russian Federation, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 60
Figure 25: Haemostasis, Russian Federation, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 62
Figure 26: Immunohaematology, Russian Federation, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 64
Figure 27: Immunohaematology, Russian Federation, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 66
Figure 28: Haematology Reagents, Russian Federation, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 68
Figure 29: Haematology Reagents, Russian Federation, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 70
Figure 30: Haematology Analyzers, Russian Federation, Revenue ($m), USD Actual, Historic, 2003-2010 72
Figure 31: Haematology Analyzers, Russian Federation, Revenue ($m), USD Actual, Forecast, 2010-2017 73
Figure 32: Haematology Rapid Tests, Russian Federation, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 74
Figure 33: Haematology Rapid Tests, Russian Federation, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 76
Figure 34: Haematology Cell Counters, Russian Federation, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 78
Figure 35: Haematology Cell Counters, Russian Federation, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 80
Figure 36: Haematology, Russian Federation, Company Share (%), 2010 83
Figure 37: Haematology, India, Overall Revenue ($m), USD Actual, 2003-2017 85
Figure 38: Haematology, India, Overall Revenue ($m), USD Actual, Historic, 2003-2010 87
Figure 39: Haematology, India, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 89
Figure 40: Haematology Reagents, India, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 91
Figure 41: Haematology Reagents, India, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 93
Figure 42: Haematology Analyzers, India, Revenue ($m), USD Actual, Historic, 2003-2010 95
Figure 43: Haematology Analyzers, India, Revenue ($m), USD Actual, Forecast, 2010-2017 96
Figure 44: Immunohaematology, India, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 97
Figure 45: Immunohaematology, India, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 99
Figure 46: Haemostasis, India, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 101
Figure 47: Haemostasis, India, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 103
Figure 48: Haematology Rapid Tests, India, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 105
Figure 49: Haematology Rapid Tests, India, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 107
Figure 50: Haematology Cell Counters, India, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 109
Figure 51: Haematology Cell Counters, India, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 111
Figure 52: Haematology, India, Company Share (%), 2010 114
Figure 53: Haematology, China, Overall Revenue ($m), USD Actual, 2003-2017 116
Figure 54: Haematology, China, Overall Revenue ($m), USD Actual, Historic, 2003-2010 118
Figure 55: Haematology, China, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 120
Figure 56: Haemostasis, China, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 122
Figure 57: Haemostasis, China, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 124
Figure 58: Haematology Reagents, China, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 126
Figure 59: Haematology Reagents, China, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 128
Figure 60: Haematology Rapid Tests, China, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 130
Figure 61: Haematology Rapid Tests, China, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 132
Figure 62: Immunohaematology, China, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 134
Figure 63: Immunohaematology, China, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 136
Figure 64: Haematology Analyzers, China, Revenue ($m), USD Actual, Historic, 2003-2010 138
Figure 65: Haematology Analyzers, China, Revenue ($m), USD Actual, Forecast, 2010-2017 139
Figure 66: Haematology Cell Counters, China, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 140
Figure 67: Haematology Cell Counters, China, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 142
Figure 68: Haematology, China, Company Share (%), 2010 145
Figure 69: Haematology, South Africa, Overall Revenue ($m), USD Actual, 2003-2017 147
Figure 70: Haematology, South Africa, Overall Revenue ($m), USD Actual, Historic, 2003-2010 149
Figure 71: Haematology, South Africa, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 151
Figure 72: Haemostasis, South Africa, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 153
Figure 73: Haemostasis, South Africa, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 155
Figure 74: Haematology Reagents, South Africa, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 157
Figure 75: Haematology Reagents, South Africa, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 159
Figure 76: Immunohaematology, South Africa, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 161
Figure 77: Immunohaematology, South Africa, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 163
Figure 78: Haematology Rapid Tests, South Africa, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 165
Figure 79: Haematology Rapid Tests, South Africa, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 167
Figure 80: Haematology Analyzers, South Africa, Revenue ($m), USD Actual, Historic, 2003-2010 169
Figure 81: Haematology Analyzers, South Africa, Revenue ($m), USD Actual, Forecast, 2010-2017 170
Figure 82: Haematology Cell Counters, South Africa, Revenue ($m), USD Actual by Segment, Historic, 2003-2010 171
Figure 83: Haematology Cell Counters, South Africa, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017 173
Figure 84: Haematology, South Africa, Company Share (%), 2010 176
Figure 85: Sysmex Corporation, Company Share (%), BRICS Haematology Market, 2010 179
Figure 86: Siemens Healthcare, Company Share (%), BRICS Haematology Market, 2010 181
Figure 87: Mindray Medical International Limited, Company Share (%), BRICS Haematology Market, 2010 183
Figure 88: Beckman Coulter, Inc., Company Share (%), BRICS Haematology Market, 2010 185
Figure 89: F. Hoffmann-La Roche Ltd., Company Share (%), BRICS Haematology Market, 2010 187
Figure 90: Bio-Rad Laboratories, Inc., Company Share (%), BRICS Haematology Market, 2010 189
Figure 91: HORIBA, Ltd., Company Share (%), BRICS Haematology Market, 2010 191
Figure 92: Abbott Laboratories, Company Share (%), BRICS Haematology Market, 2010 193
Figure 93: Grifols, S.A., Company Share (%), BRICS Haematology Market, 2010 196
Figure 94: DIAGNOSTICA STAGO, Inc., Company Share (%), BRICS Haematology Market, 2010 199